Tradestie Institutional Equity Comparison Engine
CII vs BME โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
BME Overall Edge
BME Captures Institutional Edge (1โ0 Pillars ยท 2โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Blackrock Health Sciences Trust (BME) driven by superior Momentum & Technical. Fundamentally, CII trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus BME at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, CII sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against BME sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
CII N/M vs BME N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner
BME
1Y -3.2% vs +16.7% ยท 52W Pos 44% vs 89%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
CII
NYSE
BlackRock Enhanced Large Cap Core Fund, Inc.
Institutional Equity
$22.95
-2.01% 1D
Market Cap
$948.5M
1M Return
-1.67%
1Y Return
-3.21%
Forward P/E
N/M
Unified AI Score
48.0 / 100
HOLD
Tech 49.0
Fund 52.0
Flow 50.0
Mom 54.0
BME
NYSE
Blackrock Health Sciences Trust
Institutional Equity
$47.08
-1.07% 1D
Market Cap
$487.9M
1M Return
+6.98%
1Y Return
+16.71%
Forward P/E
N/M
Unified AI Score
40.9 / 100
SELL
Tech 27.0
Fund 37.0
Flow 50.0
Mom 31.6
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
CII -3.21%
BME +16.71%
Spread: +19.92 pp (BME Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
CII TTM Op. Margin: N/A
BME TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CII vs BME. Trailing 12-month operating profitability (CII N/A vs BME N/A) and valuation multiples (CII N/M vs BME N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CII | BME | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $948.5M | $487.9M | Larger Scale | CII |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | N/A | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | N/A | N/A | Higher Margin | Tie |
| Net Profit Margin Profitability | N/A | N/A | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | N/A | N/A | Higher ROE | Tie |
| 52-Week Range Position Momentum | 44% ($20โ$26) | 89% ($38โ$48) | Stronger Trend | BME |
| Beta / 30D Volatility Risk Regime | 0.97ฮฒ ยท 22% Vol | 0.42ฮฒ ยท 19% Vol | Lower Realized Risk | BME |
| Unified Institutional Score Composite Signal | 48.0 / 100 (HOLD) | 40.9 / 100 (SELL) | Higher Composite | CII |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full CII vs BME Buy Guide
CII
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
BME
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither CII nor BME registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.